Mar 6 |
Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results
|
Mar 4 |
Belite Bio to Participate in the Leerink Partners Global Biopharma Conference
|
Feb 7 |
Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
|
Jan 9 |
Is There An Opportunity With Belite Bio, Inc's (NASDAQ:BLTE) 49% Undervaluation?
|
Nov 30 |
Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
|
Nov 20 |
Belite Bio to Participate in the BTIG Ophthalmology Day
|
Nov 15 |
Belite Bio, Inc (BLTE) Q3 2023 Earnings Call Transcript
|
Nov 15 |
Belite Bio, Inc 2023 Q3 - Results - Earnings Call Presentation
|
Nov 14 |
Belite Bio GAAP EPS of -$0.40 misses by $0.08
|
Nov 14 |
Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial Results
|